Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO

Product News   Jun 03, 2014

 
Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Gyros Protein Technologies Introduces Multi-Species Kit for Toxicokinetic Studies

Product News

Gyrolab Generic TK Kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems.

READ MORE

HORIBA Scientific Integrates AIST-NT’s Scanning Probe Microscopy Technology

Product News

Raman capabilities now range from micro- to NanoRaman and provides entry into the SPM market.

READ MORE

Thermo Fisher Scientific Expands Oncomine Portfolio

Product News

New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay, coupled with new Ion AmpliSeq HD technology, extend industry-leading Oncomine menu and enable panel design customization.

READ MORE

Like what you just read? You can find similar content on the communities below.

Applied Sciences Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE